BACKGROUND: Anal adenocarcinomas are rare cancers, constituting fewer than 10% of all anal cancers. This is a retrospective review of 10 patients with anal adenocarcinoma. PATIENTS AND METHODS: Seven men and 3 women with a median age of 59 years (range 38 to 82) participated in the study. Using the 1976 World Health Organization classification, 4 patients had the rectal type of cancer, 2 had the anal duct type, and 1 had the anorectal fistula type. The 3 remaining patients had unclassifiable tumors with solely extramucosal disease. Seven patients underwent abdominoperineal resection, 1 had a radical vulvectomy and proctectomy, and 2 had local excision. RESULTS: The median survival was 29 months (range 5 to 249). Seven patients developed a recurrence at the following sites: 2 perineal, 5 inguinal, and 5 distant metastases. Five patients died from their disease a median of 28 months after surgery, and 2 patients died of unrelated causes. Three patients are alive at a median of 54 months; 2 of these patients are free of disease and 1 has a perineal recurrence. CONCLUSION: Anal adenocarcinomas were found to be a rare, heterogeneous group of tumors with a poor prognosis despite radical surgery.
BACKGROUND: Anal adenocarcinomas are rare cancers, constituting fewer than 10% of all anal cancers. This is a retrospective review of 10 patients with anal adenocarcinoma. PATIENTS AND METHODS: Seven men and 3 women with a median age of 59 years (range 38 to 82) participated in the study. Using the 1976 World Health Organization classification, 4 patients had the rectal type of cancer, 2 had the anal duct type, and 1 had the anorectal fistula type. The 3 remaining patients had unclassifiable tumors with solely extramucosal disease. Seven patients underwent abdominoperineal resection, 1 had a radical vulvectomy and proctectomy, and 2 had local excision. RESULTS: The median survival was 29 months (range 5 to 249). Seven patients developed a recurrence at the following sites: 2 perineal, 5 inguinal, and 5 distant metastases. Five patients died from their disease a median of 28 months after surgery, and 2 patients died of unrelated causes. Three patients are alive at a median of 54 months; 2 of these patients are free of disease and 1 has a perineal recurrence. CONCLUSION: Anal adenocarcinomas were found to be a rare, heterogeneous group of tumors with a poor prognosis despite radical surgery.
Authors: Sean Warsch; Ulas Darda Bayraktar; B-Chen Wen; Joseph Zeitouni; Floriano Marchetti; Caio Max S Rocha-Lima; Alberto J Montero Journal: Gastrointest Cancer Res Date: 2012-03
Authors: I Lintzeris; X Agrogianni; P Prigouris; A Lintzeri; K Giovannakis; T Argyrakos; I Rodoyianni; S Prigouris Journal: Tech Coloproctol Date: 2011-10 Impact factor: 3.781
Authors: Michael Herfs; Patrick Roncarati; Benjamin Koopmansch; Olivier Peulen; Diane Bruyere; Alizee Lebeau; Elodie Hendrick; Pascale Hubert; Aurelie Poncin; William Penny; Nathalie Piazzon; Franck Monnien; David Guenat; Christiane Mougin; Jean-Luc Prétet; Lucine Vuitton; Karin Segers; Frederic Lambert; Vincent Bours; Laurence de Leval; Severine Valmary-Degano; Charles M Quick; Christopher P Crum; Philippe Delvenne Journal: Br J Cancer Date: 2018-04-27 Impact factor: 7.640
Authors: Rodney E Wegner; Richard J White; Shaakir Hasan; Moses Raj; Dulabh Monga; Gene Finley; Alexander V Kirichenko; James McCormick Journal: Cancer Med Date: 2019-06-07 Impact factor: 4.452